Source: Google NewsPublished on 2020-12-23
Related Articles:
- Prevail lands on a Lilly pad December 15, 2020 # # # # 2020 has been a dreadful year for most of the world – burdened by the outbreak and consequences of COVID-19. Despite this, there has been a steady stream of biotech acquisitions related to Parkinson’s which have helped to keep morale high in the PD research community. In October alone, we saw the Portuguese pharmaceutical company Bial…
- The Promise of Precision Medicine January 10, 2019 The era of precision medicine in neurology is rapidly approaching as a number of trials targeting specific genetic cohorts in Parkinson’s disease will soon be entering phase three clinical trial. However, there is a growing suspicion that these precision medicine therapies might not be precise enough and that if we are going to realize the promise that it…
- Different Patient, Different Treatment: Precision Medicine Advances for Parkinson’s Disease March 10, 2020 The discovery that abnormal cellular mechanisms are specific to distinct groups of sporadic Parkinson’s patients brings precision medicine for this neurodegenerative disorder one step closer to reality. A recent study suggests that identifying these individual disease differences and assessing neuroprotective treatments specific to each one is a promising approach to personalized treatments. The study, “Deep phenotyping of peripheral tissue facilitates…
- SHAKE, RATTLE AND ROLL: No Perfect Answer November 30, 2018 By A.C. WoolnoughReader Columnist These days, we seem to be at odds with each other about everything. We disagree on politics, religion, education, the environment, climate change, health care …The post SHAKE, RATTLE AND ROLL: No Perfect Answer appeared first on Sandpoint Reader.
- SHAKE, RATTLE AND ROLL: No Perfect Answer November 30, 2018 By A.C. WoolnoughReader Columnist These days, we seem to be at odds with each other about everything. We disagree on politics, religion, education, the environment, climate change, health care …The post SHAKE, RATTLE AND ROLL: No Perfect Answer appeared first on Sandpoint Reader.
- SHAKE, RATTLE AND ROLL: No Perfect Answer November 30, 2018 By A.C. WoolnoughReader Columnist These days, we seem to be at odds with each other about everything. We disagree on politics, religion, education, the environment, climate change, health care …The post SHAKE, RATTLE AND ROLL: No Perfect Answer appeared first on Sandpoint Reader.
- Spotlight on YOPD Council Member Gaynor Edwards October 13, 2020 This week, we’ve invited our YOPD Council leaders (Amy, Steve, Gaynor, Kat, Tom, Erin, Heather, and Kevin) to take over the blog and share their stories. We hope you’re as inspired by them as we are. Interview with Gaynor Edwards, Davis Phinney Foundation YOPD Council Leader After a few years experiencing symptoms she attributed to stress, Gaynor Edwards visited her…
- Man with Parkinson's disease throws first pitch at Pawsox game - WLNE-TV (ABC6) April 11, 2019 Man with Parkinson's disease throws first pitch at Pawsox game WLNE-TV (ABC6)To mark Parkinson's Awareness Month, a Walpole man living with the disease was invited to McCoy Stadium to throw the first pitch in Saturday's game.
- SHAKE, RATTLE AND ROLL: No Perfect Answer November 30, 2018 By A.C. WoolnoughReader Columnist These days, we seem to be at odds with each other about everything. We disagree on politics, religion, education, the environment, climate change, health care …The post SHAKE, RATTLE AND ROLL: No Perfect Answer appeared first on Sandpoint Reader.
- Are You a Victim or a Winner? October 2, 2019 When I think of a victim, I think of someone who has had something bad happen to them. A victim could be someone who has been tricked or fooled in some way. Maybe the person has been harmed, or even killed. Or it could be someone who has been affected by an illness. Enter Parkinson’s disease A diagnosis of Parkinson’s…
- 23andMe launches new diabetes risk test, but experts are wary of its benefit - MedCity News March 11, 2019 23andMe launches new diabetes risk test, but experts are wary of its benefit MedCity NewsIn contrast to its previous FDA approvals for genetic risk tests for conditions like Alzheimer's, Parkinson's Disease and colorectal cancer, the diabetes ...
- How Haven's hires hint at the healthcare organization's larger ambitions - MedCity News March 17, 2019 How Haven's hires hint at the healthcare organization's larger ambitions MedCity NewsAccording to a CNBC report, Haven's latest executive addition is Sandhya Rao, who will serve as the organization's VP of Clinical Strategy.
- Prevail Therapeutics raises $50M for gene therapy in Parkinson's, other neurodegenerative disorders - MedCity News March 27, 2019 Prevail Therapeutics raises $50M for gene therapy in Parkinson's, other neurodegenerative disorders MedCity NewsThe company hopes the funding will move it toward the clinic. Active clinical programs of gene therapies in Parkinson's include efforts by Voyager Therapeutics ...
- Medicare Advantage startup Clover Health launches drug development arm - MedCity News July 10, 2019 Medicare Advantage startup Clover Health launches drug development arm MedCity NewsMedicare Advantage startup Clover Health has started a biopharmaceutical division called Clover Therapeutics meant to use data on the insurance plans' ...
- Insightec wants to usher in a new era of incisionless surgery - MedCity News July 11, 2019 Insightec wants to usher in a new era of incisionless surgery MedCity NewsThe Israeli company's technology uses the power of focused ultrasound guided by MR imaging to target conditions like essential tremor, Parkinson's disease ...
- Acadia Pharmaceuticals drug flops in Phase III schizophrenia study - MedCity News July 23, 2019 Acadia Pharmaceuticals drug flops in Phase III schizophrenia study MedCity NewsA late-stage clinical trial of a drug under investigation for certain patients with schizophrenia who lack a Food and Drug Administration-approved therapy has ...
- Veteran life sciences venture capitalist named new CEO at Cala Health - MedCity News September 4, 2019 Veteran life sciences venture capitalist named new CEO at Cala Health MedCity NewsRenee Ryan, until recently a venture capitalist at Johnson & Johnson's venture arm, is now going to lead Burlingame, California-based Cala Health as its new ...
- Lundbeck to acquire Alder BioPharmaceuticals for nearly $2B - MedCity News September 16, 2019 Lundbeck to acquire Alder BioPharmaceuticals for nearly $2B MedCity NewsA Danish drugmaker is betting nearly $2 billion on a company based near Seattle that is awaiting a Food and Drug Administration decision on a drug for ...
- Arlington student prepares to pitch this unique product in a national competition - WJLA October 7, 2019 Arlington student prepares to pitch this unique product in a national competition WJLA
- Parkinson’s Life poetry competition: we have a winner April 10, 2019 We catch up with the winner of our first ever Parkinson’s poetry competition, Catherine Strisik, about how her entry helped her grieve for her husband – and why she wouldn’t let Parkinson’s take away the man she fell in love with We are delighted to announce the winner of our Parkinson’s poetry competition is Catherine Striisik for her poem ‘Circular…
- Perseverance in Parkinson’s March 19, 2019 “Perseverance, secret of all triumphs.” Victor Hugo “Never, never, never give in!” Winston S. Churchill Perseverance Defined: <per·se·ver·ance /ˌpərsəˈvirəns/ noun> I really like the description given by vocabulary.com, “Perseverance is not giving up. It is persistence and tenacity, the effort required to do something and keep doing it till the end, even if it’s hard. With that definition in mind, here…
- Spotlight on YOPD Council Member Heather Kennedy October 17, 2020 This week, we’ve invited our YOPD Council leaders (Amy, Steve, Gaynor, Kat, Tom, Erin, Heather, and Kevin) to take over the blog and share their stories. We hope you’re as inspired by them as we are. Written by Heather Kennedy, Davis Phinney Foundation YOPD Council Leader We’re going to talk about an up-and-coming neighborhood I call the Reasonable Boundaries District.…